Atara Biotherapeutics, Inc. (ATRA)
8.87
+0.53
(+6.35%)
USD |
NASDAQ |
May 11, 16:00
8.55
-0.32
(-3.61%)
After-Hours: 17:02
Atara Biotherapeutics Market Cap : 72.54M for May 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.734B |
| Alnylam Pharmaceuticals, Inc. | 38.03B |
| Amgen, Inc. | 177.95B |
| Savara, Inc. | 1.049B |
| Biogen, Inc. | 29.24B |
Market Cap Related Metrics
| PE Ratio | 3.043 |
| PS Ratio | 0.8088 |
| Price | 8.87 |
| Earnings Yield | 32.86% |
| Operating PE Ratio | 2.129 |
| Normalized PE Ratio | 2.362 |